 |
|
Home | Rodman & Renshaw Analysts Lower Price Target on Idera Pharmaceuticals, Inc. (IDRA) to $4.00 |
 |
Rodman & Renshaw Analysts Lower Price Target on Idera Pharmaceuticals, Inc. (IDRA) to $4.00
|
 |
- July 18, 2011
-
Equities research analysts at Rodman & Renshaw lowered their price target on shares of Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) from $6.00 to $4.00 in a research note to investors on Friday. The analysts currently have an “outperform” rating on the stock. Separately, analysts at Zacks Investment Research reiterated a “neutral” rating on shares of Idera [...]This article (Rodman & Renshaw Analysts Lower Price Target on Idera Pharmaceuticals, Inc. (IDRA) to $4.00) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2011/07/18/rodman-renshaw-analysts-lower-price-target-on-idera-pharmaceuticals-inc-idra-to-4-00/
|
 |
|
 |
|
 |
